Tomsicek Michael John

Tomsicek Michael John is listed in filings as Director at Acrivon Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including 5 public disclosures. Recent filings connect the profile to Acrivon Therapeutics, Inc. Common Stock (ACRV) and Milestone Pharmaceuticals Inc. (MIST). The current snapshot covers public activity from Jun 24, 2024 to May 20, 2026. Reported amounts are shown as $24.3K to $58.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.